ALLISON HAGEN: Open Payments
NPI 1326659368 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,344 in 97 payments from 20 companies in 2025. Trend: 2023 $1,770 · 2024 $1,458 · 2025 $2,344
Food & beverage: $2,344
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $414 |
| PFIZER INC. | 11 | $290 |
| Sumitomo Pharma America, Inc. | 14 | $265 |
| Dendreon Pharmaceuticals LLC | 8 | $227 |
| Novartis Pharmaceuticals Corporation | 8 | $213 |
| Merck Sharp & Dohme LLC | 7 | $169 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $110 |
| UROGEN PHARMA, INC. | 5 | $103 |
| Olympus America Inc. | 4 | $95 |
| ACCORD HEALTHCARE, INC. | 5 | $86 |
Products named: ERLEADA, XTANDI, PROVENGE, PLUVICTO, ORGOVYX, Nubeqa, iTIND System, Camcevi.
Industry payments across OK — which companies pay providers there.
